Trial Profile
Treatment study for severe high-density lipoprotein deficiency
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Fenofibrate (Primary) ; Niacin (Primary)
- Indications Low HDL cholesterol
- Focus Therapeutic Use
- 02 Jun 2008 Status changed from initiated to completed as reported by ClinicalTrials.gov.
- 17 Apr 2007 New trial record.